1. Product Overview
2. Research Methodology
3. Voice of Customer
4. Impact of COVID-19
on Global Ophthalmic Drugs Market
5.
Executive Summary
6. Ophthalmic Drugs
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Drug Class (Anti-Inflammatory Drugs, Anti-Infection
Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others)
6.2.2. By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye
Infection, Others)
6.2.3. By Product Type (OTC Drugs v/s Prescription Drugs)
6.2.4. By Dosage Form (Gels, Ointments, Eye Solutions, Eye
Drops, Tablets &Capsules)
6.2.5. By Route of Administration (Topical, Ocular, Systemic)
6.2.6. By Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Pharmacy)
6.2.7. By Company (2021)
6.2.8. By Region
6.3. Product Market Map
7. North America
Ophthalmic Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Indication
7.2.3. By Product Type
7.2.4. By Dosage Form
7.2.5. By Route of
Administration
7.2.6. By Distribution
Channel
7.2.7. By Country
7.3.
North America: Country Analysis
7.3.1. United States
Ophthalmic Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Indication
7.3.1.2.3.
By Product Type
7.3.1.2.4.
By Dosage Form
7.3.1.2.5.
By Route of Administration
7.3.1.2.6.
By Distribution Channel
7.3.2. Canada Ophthalmic
Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Indication
7.3.2.2.3.
By Product Type
7.3.2.2.4.
By Dosage Form
7.3.2.2.5.
By Route of Administration
7.3.2.2.6.
By Distribution Channel
7.3.3. Mexico Ophthalmic
Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Indication
7.3.3.2.3.
By Product Type
7.3.3.2.4.
By Dosage Form
7.3.3.2.5.
By Route of Administration
7.3.3.2.6.
By Distribution Channel
8. Europe Ophthalmic
Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By Product Type
8.2.4. By Dosage Form
8.2.5. By Route of Administration
8.2.6. By Distribution
Channel
8.2.7. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany Ophthalmic
Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Indication
8.3.1.2.3.
By Product Type
8.3.1.2.4.
By Dosage Form
8.3.1.2.5.
By Route of Administration
8.3.1.2.6.
By Distribution Channel
8.3.2. United Kingdom
Ophthalmic Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Indication
8.3.2.2.3.
By Product Type
8.3.2.2.4.
By Dosage Form
8.3.2.2.5.
By Route of Administration
8.3.2.2.6.
By Distribution Channel
8.3.3. France Ophthalmic
Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Indication
8.3.3.2.3.
By Product Type
8.3.3.2.4.
By Dosage Form
8.3.3.2.5.
By Route of Administration
8.3.3.2.6.
By Distribution Channel
8.3.4. Italy Ophthalmic
Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Indication
8.3.4.2.3.
By Product Type
8.3.4.2.4.
By Dosage Form
8.3.4.2.5.
By Route of Administration
8.3.4.2.6.
By Distribution Channel
8.3.5. Spain Ophthalmic
Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Indication
8.3.5.2.3.
By Product Type
8.3.5.2.4.
By Dosage Form
8.3.5.2.5.
By Route of Administration
8.3.5.2.6.
By Distribution Channel
8.3.6. Belgium Ophthalmic
Drugs Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Drug Class
8.3.6.2.2.
By Indication
8.3.6.2.3.
By Product Type
8.3.6.2.4.
By Dosage Form
8.3.6.2.5.
By Route of Administration
8.3.6.2.6.
By Distribution Channel
8.3.7. Sweden Ophthalmic
Drugs Market Outlook
8.3.7.1.
Market Size & Forecast
8.3.7.1.1.
By Value
8.3.7.2.
Market Share & Forecast
8.3.7.2.1.
By Drug Class
8.3.7.2.2.
By Indication
8.3.7.2.3.
By Product Type
8.3.7.2.4.
By Dosage Form
8.3.7.2.5.
By Route of Administration
8.3.7.2.6.
By Distribution Channel
8.3.8. Switzerland
Ophthalmic Drugs Market Outlook
8.3.8.1.
Market Size & Forecast
8.3.8.1.1.
By Value
8.3.8.2.
Market Share & Forecast
8.3.8.2.1.
By Drug Class
8.3.8.2.2.
By Indication
8.3.8.2.3.
By Product Type
8.3.8.2.4.
By Dosage Form
8.3.8.2.5.
By Route of Administration
8.3.8.2.6.
By Distribution Channel
9. Asia-Pacific
Ophthalmic Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Indication
9.2.3. By Product Type
9.2.4. By Dosage Form
9.2.5. By Route of
Administration
9.2.6. By Distribution
Channel
9.2.7. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. Japan Ophthalmic
Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Indication
9.3.1.2.3.
By Product Type
9.3.1.2.4.
By Dosage Form
9.3.1.2.5.
By Route of Administration
9.3.1.2.6.
By Distribution Channel
9.3.2. China Ophthalmic
Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.